OPGN: חובות מצטברים של החברה OpGen

OpGen, Inc. (OPGN) price action reflects the financial standing of the developer of rapid tests for detecting resistant bacteria in hospitals, with the individual debt metric standing at 0.00. The firm's operations are constrained by FDA regulations regarding biohazardous waste processing. Furthermore, the disruption of global supply chains and the sanctions regime hinder the implementation of diagnostic systems in several countries, thereby reducing potential revenue.

This indicator consolidates all of the issuer's credit obligations, allowing for an assessment of the debt load and the risks of insolvency due to interest expenses. By analyzing the total amount of borrowed funds, an investor can track the dynamics of liability restructuring at OpGen, Inc. (OPGN), which is critically important when seeking buyers for individual patents and IT assets amid the company's prolonged financial crisis.